Quantifying the feasibility of shortening clinical trial duration using surrogate markers-Reference-Cited by-同舟云学术

Quantifying the feasibility of shortening clinical trial duration using surrogate markers

Published:2021-09-02 Issue:28 Volume:40 Page:6321-6343
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Wang Xuan¹^ORCID,Cai Tianxi¹²,Tian Lu³^ORCID,Bourgeois Florence⁴,Parast Layla⁵^ORCID

Affiliation:

1. Department of Biostatistics Harvard University Boston Massachusetts USA

2. Department of Biomedical Informatics Harvard University Boston Massachusetts USA

3. Department of Biomedical Data Science Stanford University Stanford California USA

4. Harvard‐MIT Center for Regulatory Science Boston Massachusetts USA

5. Statistics Group RAND Corporation Santa Monica California USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Natural Science Foundation of China

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9185

Reference30 articles.

1. Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials

2. Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies

3. FDATable of surrogate endpoints that were the basis of drug approval or licensure; 2020.https://www.fda.gov/drugs/development‐resources/table‐surrogate‐endpoints‐we%re‐basis‐drug‐approval‐or‐licensure.

4. Surrogate endpoints in clinical trials: Definition and operational criteria

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proportion of treatment effect explained: An overview of interpretations;Statistical Methods in Medical Research;2024-07

2. Data fusion for predicting long‐term program impacts;Statistics in Medicine;2024-06-18

3. A rank-based approach to evaluate a surrogate marker in a small sample setting;Biometrics;2024-01-29

4. OSsurvival: Assessing Surrogacy with a Censored Outcome;CRAN: Contributed Packages;2022-09-29